Literature DB >> 12706365

Increased incidence of renal parenchymal carcinoma in the Northern and Yorkshire region of England, 1978-1997.

R Tate1, R Iddenden, P Harnden, E Morris, C Craigs, C Bennett, C Brook, R A Haward, D Forman.   

Abstract

Kidney cancer remains relatively rare, but incidence and mortality rates are reported to be rising steadily across the world. To determine if such increases were occurring in the UK, we examined the rates of incidence and mortality in different histological subtypes of kidney cancer in the Northern and Yorkshire region of England. Details of all 8741 cases diagnosed between 1978 and 1997 were extracted from the population-based Northern and Yorkshire Cancer Registry. For all types of tumour, both incidence and mortality rates increased over the study period. Overall age-standardised incidence rates increased by 86% for renal parenchymal carcinoma (RPC) (80% for males, 90% for females) from 2.8 to 5.2 cases per 100000 (3.8-6.8 male, 2.0-3.8 female). There were incidence increases in all age groups, all Carstairs index groups and in both urban and rural populations. Although increased incidental detection of kidney tumours by improved investigational techniques may account for some of this rise, we believe it unlikely that it accounts for all of the increase observed. Potential aetiological causes for the increased rates include hypertension, smoking, a diet lacking fruit and vegetables, analgesic use and, particularly, obesity.

Entities:  

Mesh:

Year:  2003        PMID: 12706365     DOI: 10.1016/s0959-8049(03)00070-4

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  7 in total

Review 1.  IMA901: a multi-peptide cancer vaccine for treatment of renal cell cancer.

Authors:  Alexandra Kirner; Andrea Mayer-Mokler; Carsten Reinhardt
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 2.  The physiologic and anesthetic considerations in elderly patients undergoing robotic renal surgery.

Authors:  Nikhil Vasdev; Anna Sau Kuk Poon; S Gowrie-Mohan; Tim Lane; Gregory Boustead; Damian Hanbury; James M Adshead
Journal:  Rev Urol       Date:  2014

Review 3.  The epidemiology and risk factors for renal cancer.

Authors:  Tahir Qayyum; Grenville Oades; Paul Horgan; Michael Aitchison; Joanne Edwards
Journal:  Curr Urol       Date:  2013-02-08

4.  Changing concepts in the surgery of renal cell carcinoma.

Authors:  Axel S Merseburger; Markus A Kuczyk
Journal:  World J Urol       Date:  2008-02-12       Impact factor: 4.226

5.  A cohort study of reproductive and hormonal factors and renal cell cancer risk in women.

Authors:  G C Kabat; S A Navarro Silvera; A B Miller; T E Rohan
Journal:  Br J Cancer       Date:  2007-02-20       Impact factor: 7.640

6.  Trends in the incidence and mortality of kidney cancer in Lithuania from 1993 to 2012.

Authors:  Aušvydas Patašius; Agnė Ulytė; Albertas Ulys; Giedrė Smailytė
Journal:  Acta Med Litu       Date:  2018

7.  Stage-specific incidence trends of renal cancers in the East of England, 1999-2016.

Authors:  Annie Herbert; Matthew E Barclay; Minjoung M Koo; Brian Rous; David C Greenberg; Gary Abel; Georgios Lyratzopoulos
Journal:  Cancer Epidemiol       Date:  2021-01-22       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.